Title:
A STABLE PHARMACEUTICAL FORMULATION OF PAROXETINE HYDROCHLORIDE ANHYDROUS AND A PROCESS FOR PREPARATION THEREOF
Document Type and Number:
WIPO Patent Application WO2003057151
Kind Code:
A3
Abstract:
Provided are formulations of a stable commercial paroxetine tablet comprising paroxetine hydrochloride anhydrous, povidone, copovidone or HPMC as a binder, and an HCI free/non-hygroscopic filler, prepared by the wet granulation method.
Inventors:
FOX MICHAEL (IL)
COHEN RAKEFET (IL)
BRAUNSTEIN ANNE (IL)
LEIBOVICI MINUTZA (IL)
COHEN RAKEFET (IL)
BRAUNSTEIN ANNE (IL)
LEIBOVICI MINUTZA (IL)
Application Number:
PCT/US2002/041430
Publication Date:
January 08, 2004
Filing Date:
December 27, 2002
Export Citation:
Assignee:
TEVA PHARMA (US)
TEVA PHARMA (US)
FOX MICHAEL (IL)
COHEN RAKEFET (IL)
BRAUNSTEIN ANNE (IL)
LEIBOVICI MINUTZA (IL)
TEVA PHARMA (US)
FOX MICHAEL (IL)
COHEN RAKEFET (IL)
BRAUNSTEIN ANNE (IL)
LEIBOVICI MINUTZA (IL)
International Classes:
A61K9/20; A61K9/28; A61K31/4525; (IPC1-7): A61K9/14; A61K9/16
Foreign References:
| US6150376A | 2000-11-21 | |||
| US5776969A | 1998-07-07 |
Other References:
See also references of EP 1465601A4
Download PDF: